Apogee Enterprises (APOG) director granted 153 deferred stock units

Rhea-AI Filing Summary

APOGEE ENTERPRISES, INC. director Lloyd Emerson Johnson acquired 153 deferred restricted stock units on March 31, 2026 as a grant under company director stock plans. These units were credited through a dividend equivalent reinvestment feature and are settled 1-for-1 in common stock.

The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. They will be settled in shares of common stock after Johnson’s termination from the Board or upon other events specified in the plans. Following this grant, he holds 19,264 deferred restricted stock units directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Johnson Lloyd Emerson

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Restricted Stock Units	153	$33.54	$5K

Holdings After Transaction: Deferred Restricted Stock Units — 19,264 shares (Direct)

Footnotes (1)

1. Settled 1-for-1. Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

Key Figures

Deferred restricted stock units granted: 153 units Grant reference price: $33.54 per unit Deferred units after transaction: 19,264 units +1 more

4 metrics

Deferred restricted stock units granted 153 units Grant on March 31, 2026 under director stock plans

Grant reference price $33.54 per unit Price per unit for the March 31, 2026 grant

Deferred units after transaction 19,264 units Total deferred restricted stock units following the grant

Settlement ratio 1-for-1 Each deferred restricted stock unit settles into one common share

Key Terms

Deferred Restricted Stock Units, dividend equivalent reinvestment feature, Non-Employee Director Stock Incentive Plan, settled in shares of common stock

4 terms

Deferred Restricted Stock Units financial

"security_title: "Deferred Restricted Stock Units""

Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.

dividend equivalent reinvestment feature financial

"acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan"

Non-Employee Director Stock Incentive Plan financial

"under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan"

settled in shares of common stock financial

"will be settled in shares of common stock following the director's termination from the Board"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Lloyd Emerson

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MINNESOTA 55435

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units	(1)	03/31/2026		A(2)		153		(3)	(3)	Common Stock	153	$33.54	19,264	D

Explanation of Responses:

1. Settled 1-for-1.

2. Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan.

3. The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

Remarks:

	/s/David Wright Walstrom, Attorney-in-Fact for Lloyd E. Johnson	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did APOG director Lloyd Emerson Johnson report?

Lloyd Emerson Johnson reported acquiring 153 deferred restricted stock units as a grant on March 31, 2026. The units were credited under Apogee’s non-employee director stock plans through a dividend equivalent reinvestment feature and increase his deferred stock-based compensation balance.

How many deferred restricted stock units does APOG’s director hold after this Form 4?

After this transaction, Lloyd Emerson Johnson holds 19,264 deferred restricted stock units directly. This total reflects the addition of 153 units granted on March 31, 2026 under the company’s 2009 and 2019 Non-Employee Director Stock plans for Board members.

How will the deferred restricted stock units for APOG’s director be settled?

The deferred restricted stock units will be settled in shares of Apogee common stock on a 1-for-1 basis. Settlement occurs after Johnson’s termination from the Board in accordance with his election, or upon other events specified in the applicable director stock incentive plans.

What plans govern the deferred restricted stock units reported for APOG?

The units were allocated under Apogee’s 2009 Non-Employee Director Stock Incentive Plan and 2019 Non-Employee Director Stock Plan. These plans include a dividend equivalent reinvestment feature and define when deferred restricted stock units are granted and when they are ultimately settled in common shares.

Was the APOG director’s Form 4 transaction an open-market stock purchase or sale?

No, the Form 4 shows a grant of 153 deferred restricted stock units classified as a grant, award, or other acquisition. The units were acquired under director stock incentive plans via dividend equivalent reinvestment, rather than through an open-market purchase or sale of Apogee common shares.